Table 1.
The oligonucleotides used in this study.
| Name a | Sequence (5’- > 3’) |
|---|---|
| LINC00518 F | GTGAAAATCTGGCTACTCGTCCC |
| LINC00518 R | CTGACTTTTGCCACAGACTCCTG |
| miR-185-3p F | GATCACACTCTTGTGGTAGTTGC |
| miR-185-3p R | CTCTTCCTTGCTCGTTGTTGGTAT |
| miR-185-3p mimic | AGGGGCUGGCUUUCCUCUGGUC |
| miR-185-3p mimic-NC | UUCUCCGAACGUGUCACGUTT |
| miR-185-3p inhibitor | GACCAGAGGAAAGCCAGCCCCU |
| miR-185-3p inhibitor-NC | CAGUACUUUUGUGUAGUACAA |
| MECP2 F | GCCGAGAGCTATGGACAGCA |
| MECP2 R | CCAACCTCAGACAGGTTTCCAG |
| GAPDH F | GTCAACGGATTTGGTCTGTATT |
| GAPDH R | AGTCTTCTGGGTGGCAGTGAT |
a
F: forward primer, R: reverse primer.